Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis
British journal of surgery2020Vol. 107(8), pp. 951–959
Citations Over TimeTop 10% of 2020 papers
Carolyn Cullinane, Ben Creavin, Emer O’Connell, Louise Kelly, Martin J. O’Sullivan, Mark Corrigan, H. P. Redmond
Abstract
BRCA1 and/or BRCA2 mutation carriers are not at a higher risk of colorectal cancer.
Related Papers
- → A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families(2007)27 cited
- → High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation Carriers(2008)18 cited
- Familial ovarian cancer.(2001)
- Expression of PTTG and its significance in colorectal cancer(2008)
- → Ovarian cancer in women with known BRCA mutations: How much screening is too much?(2020)